Hydroxychloroquine

Status
Phase 2
Condition
COVID-19
Intervention Type
Oral Drug
Funder Type
Organization | University

Drug Details

Hydroxychloroquine is an anti-malarial medication with immunomodulatory effects.

Study Purpose

There are multiple studies involving hydroxychloroquine and its effect on COVID-19 prevention or progression. Click the icon below to learn about the various studies.

Find a Clinical Trial

 

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >